Novel Biomarker Found to Enhance Detection of Various Inflammatory Diseases
Recent research conducted by the Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI) at Kiel University has identified a potential new biomarker for the …
Unleashing Industry Insights, Connecting the Future
Recent research conducted by the Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI) at Kiel University has identified a potential new biomarker for the …
Dr. Daniel Drucker, a renowned researcher, has been recognized for his groundbreaking work on GLP-1-based diabetes drugs. These drugs, known as GLP-1 agonists, have been …